Aclaris Therapeutics
ACRS
ACRS
108 hedge funds and large institutions have $144M invested in Aclaris Therapeutics in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
34% less capital invested
Capital invested by funds: $217M → $144M (-$73.3M)
36.6% less ownership
Funds ownership: 122.49% → 85.89% (-37%)
Holders
108
Holding in Top 10
2
Calls
$83K
Puts
$49K
Top Buyers
| 1 | +$3.33M | |
| 2 | +$2.72M | |
| 3 | +$2.18M | |
| 4 |
Morgan Stanley
New York
|
+$2.06M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.99M |
Top Sellers
| 1 | -$6.99M | |
| 2 | -$5.91M | |
| 3 | -$1.77M | |
| 4 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$1M |
| 5 |
EAM
Exome Asset Management
New York
|
-$966K |